Table 5 Multivariable Cox regression analysis for predictors of late complications related to stoma and ureteroileal anastomosis
From: An improved ileal conduit surgery for bladder cancer with fewer complications
Variable | Stoma-related complications | Ureteroileal anastomosis-related complications | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (> 62 vs. ≤ 62) | 0.238 (0.023–2.220) | 0.094 | 0.042 (0.001–1.894) | 0.103 |
Gender (female vs. male) | 1.674 (0.401–8.994) | 0.139 | 1.266 (0.108–4.569) | 0.292 |
Smoking (yes vs. no) | 0.958 (0.084–10.930) | 0.973 | 0.055 (0.002–1.435) | 0.081 |
CCI (> 2 vs. ≤ 2) | 1.950 (0.330–11.509) | 0.461 | 1.149 (0.111–11.855) | 0.207 |
ASA (> 2 vs. ≤ 2) | 1.852 (0.165–10.225) | 0.203 | 1.289 (0.041–13.672) | 0.185 |
Prior pelvic irradiation (yes vs. no) | 1.938 (0.629–9.369) | 0.292 | 2.325 (0.537–8.572) | 0.420 |
Preoperative hydronephrosis (yes vs. no) | 1.980 (0.188–10.980) | 0.287 | 3.759 (0.470–14.456) | 0.119 |
Pathologic T stage | ||||
 T2 vs. T1 | 2.259 (1.094–8.459) | 0.043 | 2.875 (1.012–5.297) | 0.032 |
 T3 vs. T2 | 1.893 (0.154–8.349) | 0.174 | 1.432 (0.023–11.242) | 0.282 |
 T4 vs. T3 | 1.564 (0.155–11.025) | 0.131 | 1.973 (0.142–9.126) | 0.259 |
Pathologic N stage (N + vs. N0) | 2.252 (0.245–12.372) | 0.219 | 3.123 (0.263–10.282) | 0.075 |
Adjuvant chemotherapy (yes vs. no) | 2.036 (0.242–6.734) | 0.178 | 1.552 (0.018–6.723) | 0.571 |
BMI (> 21.8 vs. ≤ 21.8) | 2.594 (0.121–7.783) | 0.067 | 1.934 (0.119–6.524) | 0.053 |
Year of surgery (> 2009 vs. ≤ 2009) | 2.125 (0.314–8.875) | 0.257 | 2.538 (0.423–7.243) | 0.689 |